Interaction between 'sensitized lymphocytes' and antigen in vitro. V. Vascular permeability induced by skin-reactive factor.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000941:Antigens; D007611:Aprotinin / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001780:Blood Coagulation Tests; D002199:Capillary Permeability; D002464:Cell Migration Inhibition; D002478:Cells, Cultured; D004952:Esters; D006168:Guinea Pigs; D006493:Heparin / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D007114:Immunization; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation; D007531:Isoflurophate / Q000494:pharmacology; D007734:Kymography; D008198:Lymph Nodes / Q000166:cytology; D008214:Lymphocytes / Q000276:immunology*; D008626:Mercuribenzoates / Q000494:pharmacology; D009130:Muscle, Smooth; D009169:Mycobacterium tuberculosis / Q000276:immunology; D010653:Phenylbutazone / Q000494:pharmacology; D011479:Protamines / Q000494:pharmacology; D012882:Skin Tests; D013859:Thiocarbamates / Q000494:pharmacology; D014311:Triprolidine / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000614:Aminocaproates; D000941:Antigens; D004952:Esters; D008626:Mercuribenzoates; D011479:Protamines; D013859:Thiocarbamates; D014361:Trypsin Inhibitors; D007531:Isoflurophate; D014311:Triprolidine; D006493:Heparin; D007611:Aprotinin; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin